Abstract
Tocilizumab, an interleukin-6 receptor antagonist, has been used to treat critically ill patients with coronavirus disease-2019. We present the case of a previously immunocompetent man with coronavirus disease-2019 who developed invasive pulmonary aspergillosis after treatment with tocilizumab, illustrating the importance of considering opportunistic infections when providing immune modulating therapy.
Keywords: COVID-19; aspergillosis; fungal infections; opportunistic Infections; pulmonary disease; tocilizumab.
All Keywords
【저자키워드】 COVID-19, Tocilizumab, aspergillosis, fungal infections, opportunistic Infections, pulmonary disease, 【초록키워드】 coronavirus disease, coronavirus, therapy, Tocilizumab, interleukin-6, immune, coronavirus disease-2019, Critically ill, aspergillosis, fungal infections, fungal, critically ill patients, interleukin-6 receptor, opportunistic Infections, pulmonary disease, Invasive pulmonary aspergillosis, receptor antagonist, opportunistic infection, pulmonary aspergillosis, Critically ill patient, treat, invasive, modulating, treatment with tocilizumab, 【제목키워드】 Case report, patient with COVID-19, treatment with tocilizumab,
【저자키워드】 COVID-19, Tocilizumab, aspergillosis, fungal infections, opportunistic Infections, pulmonary disease, 【초록키워드】 coronavirus disease, coronavirus, therapy, Tocilizumab, interleukin-6, immune, coronavirus disease-2019, Critically ill, aspergillosis, fungal infections, fungal, critically ill patients, interleukin-6 receptor, opportunistic Infections, pulmonary disease, Invasive pulmonary aspergillosis, receptor antagonist, opportunistic infection, pulmonary aspergillosis, Critically ill patient, treat, invasive, modulating, treatment with tocilizumab, 【제목키워드】 Case report, patient with COVID-19, treatment with tocilizumab,
{{{ 추상적인 }}}
인터루킨-6 수용체 길항제인 토실리주맙은 코로나바이러스 질환-2019로 중환자를 치료하는 데 사용되었습니다. 우리는 토실리주맙으로 치료한 후 침습성 폐 아스페르길루스증이 발병한 코로나바이러스 질병-2019에 걸린 이전의 면역 적격 남성의 사례를 제시하여 면역 조절 요법을 제공할 때 기회 감염을 고려하는 것의 중요성을 보여줍니다.
{{ 키워드: }} 코로나19; 아스페르길루스증; 곰팡이 감염; 기회 감염; 폐질환; 토실리주맙.